1zur Hausen H, Meinhof W, Scheiber W, et al. Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart vires. Int J Cancer, 1974,13 : 650 - 656.
2Gissmann L, zur Hausen H. Human papilloma virus DNA: physical mapping and genetic heterogeneity. PNAS, 1976,73 : 1310-1313.
3Gissmann L, Pfister H,zur Hausen H. Human papilloma viruses (HPV) : characterization of four different isolates. Virology,1977,76 : 569-580.
4de Villiers EM, Gissmann L, zur Hausen H. Molecular cloning of viral DNA from human genital warts. J Virol, 1981, 40 : 932 -935.
5Gissmann L, Diehl V, Schultz-Coulon H J, et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol, 1982,44 : 393 -400.
6Gissmann L, Wolnik L, Ikenberg H, et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. PNAS, 1983,80 : 560 - 563.
7Durst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. PNAS, 1983,80 : 3812 -3815.
8Boshart M, Gissmann L, Ikenberg H,et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J, 1984,3 : 1151 - 1157.
9Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papiUomavirus sequences in cervical carcinoma cells. Nature,1985,314 : 111 - 114.
10Yee C, Krishnan-Hewlett I, Baker CC, et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol, 1985;119 : 361 - 366.
5Zur Hausen H.Papillomaviruses and cancer:from basic studies to clinical application[J].Nat Rev Cancer,2002,2(5):342-350.
6Bulk S,Visser O,Rozendaal L,et al.Cervical cancer in the Netherlands 1989-1998:decrease of squamous cell carcinoma in older women,increase of adenocarcinoma in younger women[J].Int J Cancer,2005,113(6):1005-1009.
9Jenkins D.A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine:importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention[J].Gynecol Oncol,2008,110(3):18-25.
10Schwartz S M,Daling J R,Shera K A,et al.Human papillomavirus and prognosis of invasive cervical cancer:a population-based study[J].J Clin Oncol,2001,19(7):1906-1915.
